Showing results 1 to 2 of 2
Issue Date | Title | Journal Title |
---|---|---|
2022 | A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer | NATURE COMMUNICATIONS |
2019 | Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer | ONCOLOGIST |